Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 250

Results For "IMI"

4146 News Found

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
News | March 09, 2023

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Resomer used in commercial 3D-printed implants for both soft and hard tissue applications


Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules
Drug Approval | March 09, 2023

Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules

Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure


Eugia Pharma receives USFDA approval for Lenalidomide Capsules
Drug Approval | March 09, 2023

Eugia Pharma receives USFDA approval for Lenalidomide Capsules

The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone


Caplin Steriles gets USFDA approval for Thiamine Hydrochloride Injection
Drug Approval | March 09, 2023

Caplin Steriles gets USFDA approval for Thiamine Hydrochloride Injection

Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)


Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility
Drug Approval | March 09, 2023

Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)


Lonza upgrades powder characterization capabilities at Tampa
News | March 09, 2023

Lonza upgrades powder characterization capabilities at Tampa

The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation


Polson Tie-up buys 10.01% stake in Natural Biogenex
News | March 08, 2023

Polson Tie-up buys 10.01% stake in Natural Biogenex

Natural Capsules Limited's shareholding will be reduced to 89.99%


Sun Pharma completes acquisition of Concert Pharmaceuticals
News | March 07, 2023

Sun Pharma completes acquisition of Concert Pharmaceuticals

The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market


Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection
Drug Approval | March 07, 2023

Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection

Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast


Venus Remedies joins India AMR Innovation Hub
News | March 07, 2023

Venus Remedies joins India AMR Innovation Hub

lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid